Hyperlipoproteinemia medical therapy: Difference between revisions
Jump to navigation
Jump to search
Hardik Patel (talk | contribs) No edit summary |
Hardik Patel (talk | contribs) |
||
| Line 10: | Line 10: | ||
===Medical Therapy in Children and Adolescents=== | ===Medical Therapy in Children and Adolescents=== | ||
#[[Hyperlipidemia NCEP recommendations for drug therapy of high-risk hyperlipidemia in children and adolescents | Drug therapy]] | |||
#*[[Hyperlipidemia statins in children and adolescents with hyperlipidemia | Statins]] | |||
#[[Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents | Adjuvant therapies]] | |||
===[[Hypertriglyceridemia medical therapy | Pharmacotherapy]]=== | ===[[Hypertriglyceridemia medical therapy | Pharmacotherapy]]=== | ||
Revision as of 21:12, 26 October 2012
|
Lipoprotein Disorders Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hyperlipidemia requires early detection, careful evaluation and aggressive treatment with combination of therapeutic lifestyle changes and lipid-lowering drug therapies to reduce the risk of cardiovascular and cerebrovascular complications.